September 14, 2018 / 2:13 PM / 9 days ago

Allergan says aesthetics unit revenue may double by 2025

NEW YORK, Sept 14 (Reuters) - Allergan Plc said it expects revenue at its medical aesthetics unit to grow to $7 to $8 billion by 2025, even as it faces increasing competition for its blockbuster wrinkle treatment, Botox.

Revenue from the business in 2017 was $3.8 billion, Allergan said. It said the forecast implies an 8 to 10 percent compound annual growth rate.

Reporting by Michael Erman Editing by Chizu Nomiyama

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below